Clinical Trial Update: A Phase 1/ Phase 2 Study of TTHX1114(NM141) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for TTHX1114 (NM141) in corneal endothelial dystrophies, including Fuchs endothelial corneal dystrophy; trial completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Endothelial Dystrophy
• Endothelial Dysfunction
• Fuchs Endothelial Corneal Dystrophy
• Pseudophakic Bullous Keratopathy

Drugs mentioned

• TTHX1114 (NM141) (TTHX1114)

Snippet

Sponsor: Trefoil Therapeutics, Inc. | Conditions: Corneal Endothelial Dystrophy, Fuchs Endothelial Corneal Dystrophy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-10-30